Antheia Receives Phase I SBIR Award from the National Center for Complementary and Integrative Med..

The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and other valuable alkaloids, thereby providing microbial platforms for the biosynthesis of diverse plant-based medicinal compounds.

Read more at: https://www.sbir.gov/sbirsearch/detail/1246899